Hydrocortisone / neomycin / polymyxin b ophthalmic Pregnancy and Breastfeeding Warnings

Hydrocortisone / neomycin / polymyxin b ophthalmic is also known as: Cortisporin Ophthalmic Suspension, Cortomycin Suspension, Neo/PolyB/HC

Hydrocortisone / neomycin / polymyxin b ophthalmic Pregnancy Warnings

Hydrocortisone/neomycin/polymyxin B ophthalmic suspension has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity from topically administered corticosteroids. There are no controlled data in human pregnancy. This drug is only recommended during pregnancy when benefit outweighs risk.

See references

Hydrocortisone / neomycin / polymyxin b ophthalmic Breastfeeding Warnings

There are no data on the excretion of hydrocortisone/neomycin/polymyxin B ophthalmic suspension into human milk. Since orally administered corticosteroids appear in human milk and topically applied corticosteroids may be systemically absorbed, the manufacturer recommends that due to the potential for serious adverse reactions from systemically administered corticosteroids, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.